Literature DB >> 35928289

Antibody dynamics in children with first or repeat Plasmodium falciparum infections.

Eric Rogier1, Doug Nace1, Pedro R Dimbu2, Brian Wakeman1, James G Beeson3,4,5, Chris Drakeley6, Kevin Tetteh6, Mateusz Plucinski1,7.   

Abstract

Immunoglobulin (Ig) production during and after infection with Plasmodium parasites is one of the greatest adaptive immune defenses the human host has against this parasite. Infection with P. falciparum has been shown to induce different B cell maturation responses dependent upon the age of the patient, number of previous exposures, and severity of the disease. Described here are dynamics of Ig responses to a panel of 32 P. falciparum antigens by patients followed for 42 days and classified individuals as showing characteristics of an apparent first P. falciparum infection (naïve) or a repeat exposure (non-naïve). Six parameters were modeled to characterize the dynamics of IgM, IgG1, IgG3, and IgA for these two exposure groups with differences assessed among Ig isotypes/subclasses and unique antigens. Naïve patients had significantly longer periods of time to reach peak Ig titer (range 4-7 days longer) and lower maximum Ig titers when compared with non-naïve patients. Modeled time to seronegativity was significantly higher in non-naïve patients for IgM and IgA, but not for the two IgG subclasses. IgG1 responses to Rh2030, HSP40, and PfAMA1 were at the highest levels for non-naïve participants and may be used to predict previous or nascent exposure by themselves. The analyses presented here demonstrate the differences in the development of the Ig response to P. falciparum if the infection represents a boosting response or a primary exposure. Consistency in Ig isotype/subclasses estimates and specific data for P. falciparum antigens can better guide interpretation of seroepidemiological data among symptomatic persons.
Copyright © 2022 Rogier, Nace, Dimbu, Wakeman, Beeson, Drakeley, Tetteh and Plucinski.

Entities:  

Keywords:  antibodies; boosting; exposure; isotypes; malaria

Year:  2022        PMID: 35928289      PMCID: PMC9343764          DOI: 10.3389/fmed.2022.869028

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  52 in total

1.  Dynamics of PfEMP1 Antibody Profile From Birth to 12 Months of Age in Beninese Infants.

Authors:  A Moussiliou; L Turner; G Cottrell; J Doritchamou; K Gbédandé; N Fievet; A J F Luty; A Massougbodji; T G Theander; P Deloron; T Lavstsen; N Tuikue Ndam
Journal:  J Infect Dis       Date:  2020-06-11       Impact factor: 5.226

2.  Evaluation of Immunoglobulin G Responses to Plasmodium falciparum and Plasmodium vivax in Malian School Children Using Multiplex Bead Assay.

Authors:  Eric Rogier; Delynn M Moss; Anna N Chard; Victoria Trinies; Seydou Doumbia; Matthew C Freeman; Patrick J Lammie
Journal:  Am J Trop Med Hyg       Date:  2016-11-28       Impact factor: 2.345

3.  Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development.

Authors:  Jack S Richards; Thangavelu U Arumugam; Linda Reiling; Julie Healer; Anthony N Hodder; Freya J I Fowkes; Nadia Cross; Christine Langer; Satoru Takeo; Alex D Uboldi; Jennifer K Thompson; Paul R Gilson; Ross L Coppel; Peter M Siba; Christopher L King; Motomi Torii; Chetan E Chitnis; David L Narum; Ivo Mueller; Brendan S Crabb; Alan F Cowman; Takafumi Tsuboi; James G Beeson
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

4.  The generation and evaluation of recombinant human IgA specific for Plasmodium falciparum merozoite surface protein 1-19 (PfMSP1 19).

Authors:  Jianguo Shi; Richard S McIntosh; Jaime Adame-Gallegos; Prabhjyot K Dehal; Marjolein van Egmond; Jan van de Winkel; Simon J Draper; Emily K Forbes; Patrick H Corran; Anthony A Holder; Jenny M Woof; Richard J Pleass
Journal:  BMC Biotechnol       Date:  2011-07-22       Impact factor: 2.563

5.  Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function.

Authors:  Silvia Portugal; Christopher M Tipton; Haewon Sohn; Younoussou Kone; Jing Wang; Shanping Li; Jeff Skinner; Kimmo Virtaneva; Daniel E Sturdevant; Stephen F Porcella; Ogobara K Doumbo; Safiatou Doumbo; Kassoum Kayentao; Aissata Ongoiba; Boubacar Traore; Inaki Sanz; Susan K Pierce; Peter D Crompton
Journal:  Elife       Date:  2015-05-08       Impact factor: 8.140

6.  Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.

Authors:  Faith Ha Osier; Gaoqian Feng; Michelle J Boyle; Christine Langer; Jingling Zhou; Jack S Richards; Fiona J McCallum; Linda Reiling; Anthony Jaworowski; Robin F Anders; Kevin Marsh; James G Beeson
Journal:  BMC Med       Date:  2014-07-01       Impact factor: 8.775

7.  Multiplexing detection of IgG against Plasmodium falciparum pregnancy-specific antigens.

Authors:  Ana Maria Fonseca; Llorenç Quinto; Alfons Jiménez; Raquel González; Azucena Bardají; Sonia Maculuve; Carlota Dobaño; Maria Rupérez; Anifa Vala; John J Aponte; Esperanza Sevene; Eusebio Macete; Clara Menéndez; Alfredo Mayor
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

8.  Selection of Antibody Responses Associated With Plasmodium falciparum Infections in the Context of Malaria Elimination.

Authors:  Lotus L van den Hoogen; Gillian Stresman; Jacquelin Présumé; Ithamare Romilus; Gina Mondélus; Tamara Elismé; Alexandre Existe; Karen E S Hamre; Ruth A Ashton; Thomas Druetz; Vena Joseph; James G Beeson; Susheel K Singh; Jacques Boncy; Thomas P Eisele; Michelle A Chang; Jean F Lemoine; Kevin K A Tetteh; Eric Rogier; Chris Drakeley
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

9.  Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth Cohort.

Authors:  Arlene E Dent; Indu Malhotra; Xuelie Wang; Denise Babineau; Kee Thai Yeo; Timothy Anderson; Rhonda J Kimmel; Evelina Angov; David E Lanar; David Narum; Sheetij Dutta; Jack Richards; James G Beeson; Brendan S Crabb; Alan F Cowman; Toshihiro Horii; Eric Muchiri; Peter L Mungai; Christopher L King; James W Kazura
Journal:  Clin Vaccine Immunol       Date:  2015-12-09

10.  In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP).

Authors:  Merricka C Livingstone; Alexis A Bitzer; Alish Giri; Kun Luo; Rajeshwer S Sankhala; Misook Choe; Xiaoyan Zou; S Moses Dennison; Yuanzhang Li; William Washington; Viseth Ngauy; Georgia D Tomaras; M Gordon Joyce; Adrian H Batchelor; Sheetij Dutta
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.